Otitis Externa (OE)

 
FLOXIN Otic and FLOXIN Otic SINGLES are effective in OE due to Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli in pediatric and adult patients 6 months of age and older.
   
FLOXIN Otic and FLOXIN Otic SINGLES are FDA approved for once-daily dosing for OE
   
Powerful pathogen eradication and clinical cure rates1,2
   
Pathogen

Study 016/0172

Study 0201
Eradication
Rate		 Clinical Cure
Rate		 Eradication
Rate		 Clinical Cure
Rate
P.aeruginosa 98.9% 96.8% 96.8% 90.5%
S.aureus * * 96.9% 75%
E. coli * * 92.3% 92.3%
*There was an insufficient number of patients with this organism in the study population to assess efficacy.


 

Please see full prescribing information
 

FLOXIN® Otic and FLOXIN® Otic SINGLES® are only available by prescription.
A doctor can determine if FLOXIN® Otic or FLOXIN® Otic SINGLES® is right for you.
This site is intended for use by residents of the United States.
Click here for Important Safety Information.

Terms of Use and Privacy Policy